AngioDynamics Xcela® Port Catheter Lawsuit

Lawsuits are being filed against AngioDynamics by patients who were injured by an Xcela Port Catheter.

What You Can Do & How We Can Help

The Schmidt Firm, PLLC is currently accepting AngioDynamics Xcela Port Catheter cases in all 50 states. If you were injured or needed surgery for problems with an Xcela Port Catheter, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Medical Device Litigation Group or call toll free 24 hours a day at (866) 920-0753.

What is the Problem?

Lawsuits claim that the Xcela Port Catheter is defective because it was manufactured with too high a concentration of barium sulfate in the catheter material.

This manufacturing flaw “led to an irregular catheter surface replete with fissure, pits and cracks,” which allegedly increases the risk of injuries like blood clots, catheter fracture, infection, or needing surgery.

According to these lawsuits:

“The roughened catheter surface leads to the collection and proliferation of fibrinous blood products, thereby drastically increasing the risk of thromboembolism, catheter fracture, and/or infection.”

What is the Safety Risk?

Lawsuits claim that AngioDynamics knew Xcela was not safe, but did not issue a recall or warn the public about safety risks, such as:

Death
Catheter fracture
Hemorrhage (severe bleeding)
Thromboembolism (blood clots)
Infection / sepsis
Heart problems (such as cardiac tamponade)
Cardiac arrhythmia
Pain
Perforations of tissue, blood vessels, and organs
Needing another surgery to remove Xcela

Xcela Lawsuits Centralized in Multi-District Litigation (MDL)

In February 2025, judges consolidated the Xcela litigation into a single federal court in San Diego, California. The order transferred about 90 lawsuits for port catheter injuries to a Multi-District Litigation (MDL).

The U.S. District Court for the Southern District of California (San Diego) is now overseeing the consolidated Multi-District Litigation (MDL No. 3125) under U.S. District Judge Jinsook Ohta.

The MDL is also known as: IN RE: AngioDynamics, Inc., and Navilyst Medical, Inc., Port Catheter Products Liability Litigation.

What Do Xcela Lawsuits Claim?

All of these lawsuits allege that the catheter component of the port devices were manufactured with an “excessive concentration of barium sulfate, causing the material to degrade and the surface of the catheter to pit or crack. As a result, plaintiffs contend, the catheters are prone to fracture and to collect fibrinous blood products, which causes perforation, infections, and blood clots, among other injuries.”

Xcela Lawsuits Against AngioDynamics and Navilyst

The MDL defendants are AngioDynamics and its subsidiary Navilyst Medical. These companies sell several port catheter devices, such as:

Xcela Port Catheter
Xcela Plus Port Catheter
Vortex Port Catheter
BioFlo Port Catheter
SmartPort CT Catheter
Navilyst PowerPort

Xcela Lawsuit Filed By Cancer Patient

In March 2025, a lawsuit was filed against AngioDynamics by Frank B., a man from Oregon who developed severe pain, blood clots, and needed surgery to remove Xcela about a year after it was implanted.

He was diagnosed with an acute embolism and thrombosis, which are injuries that occur when blood clot suddenly blocks a blood vessel. Doctors traced these injuries to his Xcela Port Catheter, according to his lawsuit. He had surgery to remove the Xcela port in June 2023.

His lawsuit was filed on March 17, 2025, and transferred into the federal MDL — Case 3:25-cv-00623-JO-VET.

What is the Xcela Port?

The Xcela Port Catheter is a medical device that is implanted completely under a patient’s skin for long-term venous access. It is designed to give healthcare professionals easy repeated access to a patient’s veins for blood draws, or the delivery of medications (such as chemotherapy), IV fluids, blood transfusions, or nutritional solutions.

Xcela Port Catheters for Chemotherapy Patients

The advantage of an Xcela Port Catheter is that patients do not need repeated needle-sticks, which can damage delicate veins over time.

Xcela and similar devices are also called “chemo ports” because they are so commonly used to administer chemotherapy to cancer patients.

Chemotherapy medications can easily destroy small veins near the surface of the skin, but port catheters help avoid this type of injury by delivering chemotherapy into large central veins deep inside the body.

How Does Xcela Work?

Xcela is a type of medical device called a Totally Implantable Venous Access Device (TIVAD). There are many varieties, but they all have two main parts: an injection port and a catheter.

The injection port is implanted completely under the skin, with a soft raised center called a “septum” where the needle is inserted. The port is connected to a catheter, which is a long flexible tube that is inserted into one of the large central veins that delivers blood to the heart.

Hundreds of Port Catheter Lawsuits Have Been Filed Nationwide

A growing number of lawsuits have been filed by people who were injured by port catheter devices, including many cancer patients.

These devices were advertised to help patients avoid needle-sticks, but instead, many patients were injured when a defective implant broke, leaked, caused complications, or had to be removed.

Hundreds of lawsuits involve the Bard PowerPort. Lawyers claim the PowerPort has a similar design flaw as the Xcela, with too much barium sulfate in the catheter material. This allegedly increases the risk of catheter fracture, blood clots, infections, and other injuries.

Do I Have an Xcela Port Catheter Lawsuit?

Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.

AngioDynamics Xcela Port Catheter Lawsuit